Does BIMEKIZUMAB Cause Ankylosing spondylitis? 94 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Ankylosing spondylitis have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 3.8% of all adverse event reports for BIMEKIZUMAB.
94
Reports of Ankylosing spondylitis with BIMEKIZUMAB
3.8%
of all BIMEKIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Ankylosing spondylitis From BIMEKIZUMAB?
Of the 94 reports, 1 (1.1%) required hospitalization.
Is Ankylosing spondylitis Listed in the Official Label?
Yes, Ankylosing spondylitis is listed as a known adverse reaction in the official FDA drug label for BIMEKIZUMAB.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
What Other Drugs Cause Ankylosing spondylitis?
CERTOLIZUMAB PEGOL (2,580)
ADALIMUMAB (2,378)
SECUKINUMAB (1,942)
ETANERCEPT (1,456)
METHOTREXATE (1,067)
DICLOFENAC (874)
INFLIXIMAB (789)
GOLIMUMAB (643)
LEFLUNOMIDE (413)
CELECOXIB (329)
Which BIMEKIZUMAB Alternatives Have Lower Ankylosing spondylitis Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN